Purpose-Built AI
InfinityAI leverages advanced AI to unlock clinically meaningful insights and novel biomarkers from complex, multimodal, longitudinal data.
Identify more patients eligible for a therapy with a novel biomarker*
61% post 1st line ET ESR1- patients that still benefit from SERD therapy
Get Cancer Tumor Type Predictions from Molecular Testing
Razavi et al. SABCS Poster 2025.
*Feature is for Research Use Only. Not for use in diagnostic procedures.
InfinityAI is not a standalone customer product. Products powered by InfinityAI refers to Guardant Health's artificial intelligence and machine learning technology used in development of product features. These features are reported as professional service and have not been cleared or approved by the US FDA.
Home Guardant Infinity™ for BioPharma Guardant360® CDx for BioPharma InfinityAI for BioPharma